» Articles » PMID: 11961225

Evaluation of the Aromatase Inhibitor Fadrozole in a Short-term Reproduction Assay with the Fathead Minnow (Pimephales Promelas)

Overview
Journal Toxicol Sci
Specialty Toxicology
Date 2002 Apr 19
PMID 11961225
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Cytochrome P450 aromatase (CYP19) is a key enzyme in vertebrate steroidogenesis, catalyzing the conversion of C19 androgens to C18 estrogens such as beta-estradiol (E2). The objective of this study was to assess effects of the CYP19 inhibitor fadrozole on fathead minnow (Pimephales promelas) reproductive endocrinology and physiology in a short-term reproduction assay proposed for identifying specific classes of endocrine-disrupting chemicals. A concentration-dependent reduction in fecundity was observed in fish exposed for 21 days to water concentrations of fadrozole ranging from 2 to 50 microg/l. Consistent with the expected mechanism of action, there was a significant inhibition of brain aromatase activity in both male and female fathead minnows exposed to fadrozole. In females, this inhibition was accompanied by a concentration-dependent decrease in plasma E2 and vitellogenin concentrations; the latter observation is consistent with the fact that activation of the estrogen receptor by E2 initiates hepatic vitellogenin production in oviparous vertebrates. Histological assessment of ovaries from females exposed to fadrozole indicated a decrease in mature oocytes and an increase in preovulatory atretic follicles. Exposure of male fathead minnows to fadrozole significantly increased plasma concentrations of the androgens testosterone (T) and 11-ketotestosterone (KT) and resulted in a marked accumulation of sperm in the testes. Results of this study indicate that the proposed fathead minnow assay should effectively identify test chemicals as potential aromatase inhibitors, both in the context of their reproductive toxicity and the specific mechanism of action. These results also should be of utility in assessing the potential ecological risk of CYP19 inhibitors, in particular in the context of relating alterations in subcellular indicators of endocrine function (changes in steroids, proteins) to adverse consequences in the whole organism.

Citing Articles

Role of a non-steroidal aromatase inhibitor on growth performance, body composition, reproductive and serum biochemical indices, and intestinal histomorphology in hybrid red tilapia (Oreochromis spp.).

Syanya F, Mahadevan H, Khanna A, Mathia W, Mumina P Fish Physiol Biochem. 2025; 51(1):45.

PMID: 39920535 DOI: 10.1007/s10695-025-01458-2.


Estradiol reduction through aromatase inhibition impairs cocaine seeking in male rats.

Alvarado-Torres J, Morales-Silva R, Sanabria Ponce de Leon A, Rodriguez-Torres G, Perez-Torres J, Perez-Perez Y Front Behav Neurosci. 2024; 17:1307606.

PMID: 38292056 PMC: 10824998. DOI: 10.3389/fnbeh.2023.1307606.


Discovery of a Potent Dual Inhibitor of Aromatase and Aldosterone Synthase.

Tinivella A, Banchi M, Gambacorta G, Borghi F, Orlandi P, Baxendale I ACS Pharmacol Transl Sci. 2023; 6(12):1870-1883.

PMID: 38093846 PMC: 10714424. DOI: 10.1021/acsptsci.3c00183.


Mutation of brain aromatase disrupts spawning behavior and reproductive health in female zebrafish.

Shaw K, Therrien M, Lu C, Liu X, Trudeau V Front Endocrinol (Lausanne). 2023; 14:1225199.

PMID: 37435485 PMC: 10332311. DOI: 10.3389/fendo.2023.1225199.


Sea Anemones Responding to Sex Hormones, Oxybenzone, and Benzyl Butyl Phthalate: Transcriptional Profiling and Modelling Provide Clues to Decipher Endocrine Disruption in Cnidarians.

Morgan M, Ross J, Ellwanger J, Phrommala R, Youngblood H, Qualley D Front Genet. 2022; 12:793306.

PMID: 35087572 PMC: 8787064. DOI: 10.3389/fgene.2021.793306.